BIO-key International is trading 7.4% lower at $2.44 on October 19, 2026, with no new company-specific announcement identified to explain the decline.
- The latest company releases found were dated October 13.
- Shares fell 10.85% to $2.63 on October 16.
- Technology-sector weakness has been linked to investor concerns about AI infrastructure debt and borrowing costs, but no clear evidence ties that pressure directly to BIO-key International’s move today.